Vivian Bouet, SVP Chief Information and Digital Officer at Greif, Inc., filed a Form 4 on November 4, 2026, disclosing the acquisition of 3,514 restricted stock units in a transaction dated November 2, 2026.
Alexander Johansson, SVP SBU/GM Steel Solutions at Greif, Inc., filed a Form 4 on November 4, 2026, disclosing the acquisition of 1,932 restricted stock units tied to Class A common stock and noting a correction to a previously underreported RSU balance.
Medicus Pharma Ltd. filed a Form 8-K on November 4, 2026, disclosing under Regulation FD that it issued a press release announcing a non-binding letter of intent related to a potential business combination involving its wholly-owned subsidiary, Skinject, Inc., and an undisclosed special purpose …
Medicus Pharma Ltd. filed a Form 425 (filed as a current report under Item 7.01 Regulation FD Disclosure) on November 4, 2026, announcing a non-binding letter of intent for a potential business combination involving its wholly-owned subsidiary, Skinject, Inc., and an undisclosed special purpose …
Saba Capital Management, L.P. filed a Form 4 on November 4, 2026, disclosing a purchase of 100 shares of Gabelli Healthcare & WellnessRx Trust common stock on November 3, 2026.
Infleqtion, Inc. Chief Financial Officer Ilan Hart filed a Form 4 on November 4, 2026, reporting a November 3, 2026 transaction in which 24,365 shares of common stock were withheld by the issuer to satisfy tax obligations tied to the vesting of restricted stock …
Nippon Life Insurance Co filed a Form 4 with the SEC on November 4, 2026, disclosing a purchase of 190,251 shares of Corebridge Financial, Inc. common stock on November 2, 2026, under a Rule 10b5-1 plan.
Teresa Marie Bitetti, President of the Oncology Business Unit at Takeda Pharmaceutical Co Ltd, filed a statement of changes in beneficial ownership on November 4, 2026, disclosing a sale of American Depositary Shares on November 2, 2026.
Matthew Neagle, Chief Operating Officer of Porch Group, Inc. (NASDAQ:PRCH), filed a Form 4 on November 4, 2026, disclosing the sale of 56,250 shares of common stock on November 2, 2026, pursuant to a Rule 10b5-1 trading plan.
Justin B. Stiefel, CEO, Treasurer, and Director of IP Strategy Holdings, Inc. (NASDAQ:IPST), filed a Form 4 on November 4, 2026, disclosing RSU vesting transactions dated November 2, 2026, that resulted in both the acquisition of common stock and the relinquishment of shares to …